Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. KFY
5. ABBV
6. MU
7. DPZ
8. NAVN
9. DFTX
10. NVEC

Go back to Sage Therapeutics Announces Second Quarter 2024 Financial Results and Highlights Pipeline and Business Progress

Sage Therapeutics (SAGE) PT Lowered to $15 at Stifel

August 1, 2024 6:40 AM EDT

Stifel analyst Paul Matteis lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $15.00 (from $20.00) while maintaining a Hold rating.

The analyst comments "Zurzuvae continues to launch reasonably well in PPD, coming in a hair above consensus despite a significant inventory drawdown. Meanwhile... More